These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 6308622)

  • 21. A 2.4-kilobase-pair fragment of the Friend murine leukemia virus genome contains the sequences responsible for friend murine leukemia virus-induced erythroleukemia.
    Oliff A; Ruscetti S
    J Virol; 1983 Jun; 46(3):718-25. PubMed ID: 6574260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
    Vogt M; Haggblom C; Swift S; Haas M
    J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
    Fan H; Chute H; Chao E; Pattengale PK
    Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
    Manley NR; O'Connell MA; Sharp PA; Hopkins N
    J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
    Fan H; Chute H; Chao E; Feuerman M
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5965-9. PubMed ID: 6310608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
    Masuda M; Remington MP; Hoffman PM; Ruscetti SK
    J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Friend and Moloney murine leukemia viruses specifically recombine with different endogenous retroviral sequences to generate mink cell focus-forming viruses.
    Evans LH; Cloyd MW
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):459-63. PubMed ID: 2578666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic basis of disease specificity of nondefective Friend murine leukemia virus.
    Hopkins N
    Ann N Y Acad Sci; 1989; 567():14-25. PubMed ID: 2679314
    [No Abstract]   [Full Text] [Related]  

  • 32. M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors.
    van der Putten H; Quint W; van Raaij J; Maandag ER; Verma IM; Berns A
    Cell; 1981 Jun; 24(3):729-39. PubMed ID: 7249080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
    Stocking C; Kollek R; Bergholz U; Ostertag W
    Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
    Mukhopadhyaya R; Richardson J; Nazarov V; Corbin A; Koller R; Sitbon M; Wolff L
    J Virol; 1994 Aug; 68(8):5100-7. PubMed ID: 7518530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
    van der Putten H; Quint W; Verma IM; Berns A
    Nucleic Acids Res; 1982 Jan; 10(2):577-92. PubMed ID: 6278422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
    Ott DE; Keller J; Sill K; Rein A
    J Virol; 1992 Oct; 66(10):6107-16. PubMed ID: 1326661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
    Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
    J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.